Overview of cell death signaling pathways

Z **, WS El-Deiry - Cancer biology & therapy, 2005‏ - Taylor & Francis
Apoptosis plays an important role in development and maintenance of tissue homeostasis.
Intensive efforts have been made to explore the molecular mechanisms of the apoptotic …

The multifaceted role of TRAIL signaling in cancer and immunity

L Cardoso Alves, N Corazza, O Micheau… - The FEBS …, 2021‏ - Wiley Online Library
Tumor necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) is a member of the
TNF superfamily that can lead to the induction of apoptosis in tumor or infected cells …

Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies

YC Sung, PR **, LA Chu, FF Hsu, MR Wang… - Nature …, 2019‏ - nature.com
Abnormal tumour vasculature has a significant impact on tumour progression and response
to therapy. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis …

Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects

JE Allen, G Krigsfeld, PA Mayes, L Patel… - Science translational …, 2013‏ - science.org
Recombinant tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is an
antitumor protein that is in clinical trials as a potential anticancer therapy but suffers from …

Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder

SG Fillman, D Sinclair, SJ Fung, MJ Webster… - Translational …, 2014‏ - nature.com
Schizophrenia and bipolar disorder share a number of common features, both
symptomatically and biologically. Abnormalities in the neuroimmune and the stress …

Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death

MS Ricci, SH Kim, K Ogi, JP Plastaras, J Ling, W Wang… - Cancer cell, 2007‏ - cell.com
Cells expressing oncogenic c-Myc are sensitized to TNF superfamily proteins. c-Myc also is
an important factor in determining whether a cell is sensitive to TRAIL-induced apoptosis …

Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice

S Ganai, RB Arenas, NS Forbes - British journal of cancer, 2009‏ - nature.com
Background: An effective cancer therapeutic must selectively target tumours with minimal
systemic toxicity. Expression of a cytotoxic protein using Salmonella typhimurium would …

The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

S Wang - Oncogene, 2008‏ - nature.com
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the
TNF superfamily and has been shown to induce apoptosis in cancer cells but not normal …

Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor–related apoptosis-inducing ligand receptor activating agents

EK Rowinsky - Journal of Clinical Oncology, 2005‏ - ascopubs.org
Targeted induction of programmed cell death or apoptosis via the extrinsic apoptotic
pathway represents an unexploited therapeutic strategy to destroy cancer cells. The …

The promise of TRAIL—potential and risks of a novel anticancer therapy

R Koschny, H Walczak, TM Ganten - Journal of molecular medicine, 2007‏ - Springer
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising new
anticancer biotherapeutic. As shown by many preclinical studies, TRAIL efficiently induces …